What do healthcare teams get wrong about protecting older medical devices and legacy systems?

A common mistake is treating legacy medical technology as an isolated IT problem instead of part of the clinical attack surface. Older, unpatched devices often remain connected to core systems, creating easy entry points for attackers. Security teams need inventory, segmentation, patch prioritisation, and retirement planning, because outdated equipment can undermine both patient safety and broader security controls.

What healthcare teams miss about legacy medical device risk

Older medical devices are often treated as if they sit outside normal security planning, but they usually remain part of the same clinical, network, and identity environment as modern systems. The core mistake is to treat age as a reason to defer control work. In practice, legacy systems need explicit ownership, inventory, segmentation, and a retirement path.

That matters because many older devices were never designed for current threat conditions. They may not support modern authentication, logging, or timely patching, so compensating controls become the real defense. For healthcare teams, the question is not whether the device is “supported” in a vendor sense, but whether it can still be safely operated in the live clinical environment.

Legacy risk also behaves differently from ordinary endpoint risk. A device that looks isolated may still connect to EHRs, imaging platforms, medication workflows, or shared clinical networks. That means a weak device can become a bridge into systems that affect care delivery, which is why Healthcare Identity Security Guide is useful for understanding how clinical access, shared workstations, and medical device exposure intersect in one operating model.

Why “just patch it” is not a safe plan

Patch availability is only one constraint, and often not the main one. Some legacy devices cannot be patched without vendor approval, recertification, downtime, or clinical disruption. Others are patched so rarely that teams lose track of whether the device is actually covered by current maintenance and configuration standards.

The safer posture is to separate devices into three operational buckets: patchable now, protect with compensating controls, and plan to retire. That distinction matters because a patching queue alone does not reduce risk if the device remains exposed, overconnected, or impossible to monitor. A legacy system that cannot be updated should be treated as a controlled exception, not a hidden normal.

Control design should also reflect the clinical blast radius. If a device can influence diagnosis, treatment, or downstream data integrity, the security issue is no longer confined to IT hygiene. It becomes a patient-safety and availability problem as well, and that changes how aggressively the team should isolate, monitor, or replace it.

What good protection looks like in practice

Effective protection starts with a complete inventory that includes model, software version, owner, network path, vendor support status, and clinical dependency. Without that baseline, teams cannot make sensible decisions about segmentation, exceptions, or retirement timing. Inventory is not a documentation exercise, it is the control that makes every other decision possible.

Segmentation should then reduce what the device can reach and who can reach it. For many legacy systems, the right target is not full modernization but narrower trust boundaries, tighter administrative access, and fewer direct dependencies on enterprise services. That is why NIST Cybersecurity Framework 2.0 is a useful organising model: identify the asset, protect it with appropriate controls, detect abnormal behaviour, respond to issues, and recover in a way that preserves clinical operations.

Retirement planning is equally important. A device that is no longer supportable should have a replacement or decommission path, not an indefinite exception. If a system remains in service because it is “still working,” the organisation is accepting a risk decision without a real end date, which is how legacy exposure quietly accumulates.

Risk and Threat Considerations

legacy medical device are attractive because they often combine weak patchability with persistent connectivity. An attacker does not need every device to be exploitable, only one reachable weak point that can later be used to move deeper into the environment or disrupt care delivery. The risk increases when the device is trusted by adjacent systems or assumed to be low priority.

Failure mechanism: Outdated devices remain on active networks, cannot be hardened to modern standards, and are often left with broad reachability or weak administrative controls. That creates an easy entry path, then a path to segmentation failure, credential abuse, or operational disruption.

Impact: The result can be unauthorised access, clinical outage, corrupted workflows, delayed treatment, or a wider security incident that extends beyond the device itself. In healthcare, that can affect both confidentiality and patient safety.

Standards & Framework Alignment

This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.

NIST CSF 2.0 and CIS Controls v8 set the governance and control requirements practitioners need to meet.

Framework	Control / Reference	Relevance
NIST CSF 2.0	ID.AM-01 — Asset Inventory	Legacy medical devices must be inventoried to manage exposure and dependencies.
	PR.AA-05 — Least Privilege	Segmenting and limiting access reduces the blast radius of unsupported devices.
	PR.PS-01 — Baseline Configuration Management	Legacy systems need controlled configurations when patching is limited or slow.
Recommendation — Maintain a complete inventory of legacy devices, owners, versions, and network dependencies. Restrict device reachability and administrative access to the minimum necessary. Apply hardened baselines and document compensating controls for unpatchable devices.
CIS Controls v8	CIS-1 — Inventory and Control of Enterprise Assets	Legacy device risk starts with knowing what is connected and where.
Recommendation — Track every legacy medical device, its owner, and its connectivity path.

Practitioner Guidance

What to prioritise: Start with devices that are both unsupported and network-reachable, especially those tied to clinical workflows or shared infrastructure. Those are the systems most likely to create disproportionate risk even if they appear stable day to day.

What to verify: Confirm whether each legacy device has an owner, an approved network location, a support status, and a replacement plan. If any of those are missing, the device is already operating outside mature control.

Common mistake: Teams often focus on whether the device can be patched, then stop there. The better question is whether the device can be safely contained, monitored, and eventually removed if patching is not realistic.

Practitioner takeaway: Older medical technology is rarely just an IT exception, it is a live clinical trust problem, and the right response is to manage exposure deliberately rather than hope that age and stability are the same thing.